Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New potential oral cancer therapy developed in Korea

April 13, 2012

Small ApoA-I mimetic is atheroprotective and can be used to image atherosclerotic plaques

April 13, 2012

Zannan and AB Pharma develop novel highly potent HCV NS3/NS4A inhibitor

April 13, 2012

Merck & Co. discovers new potential schizophrenia therapies

April 12, 2012

Amgen reports discovery of novel class of prostanoid EP2 receptor antagonists

April 12, 2012

First-in-human data presented on hypomethylating anticancer agent

April 12, 2012

Tetraphase Pharmaceuticals describes antibacterial activity of novel pentacycline

April 12, 2012

Scientists in U.S. develop new mouse model to study radiation effects

April 12, 2012

New orally bioavailable TTK inhibitor described

April 12, 2012

Novel ApoA-I-mimetic peptide shows promise as atherosclerosis drug

April 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...